Cargando…

Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea

OBJECTIVES: Herpes simplex virus (HSV) infections have been reported in 60% to 95% of the adult population worldwide, making them one of the most common infectious conditions globally. HSV-1 and HSV-2 cause severe disease in immunocompromised patients. Therefore, the aim of this study was to provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Eun Ju, Yuk, Young Sam, Kim, Jae Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korea Disease Control and Prevention Agency 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721267/
https://www.ncbi.nlm.nih.gov/pubmed/34965687
http://dx.doi.org/10.24171/j.phrp.2021.0146
_version_ 1784625301834170368
author Oh, Eun Ju
Yuk, Young Sam
Kim, Jae Kyung
author_facet Oh, Eun Ju
Yuk, Young Sam
Kim, Jae Kyung
author_sort Oh, Eun Ju
collection PubMed
description OBJECTIVES: Herpes simplex virus (HSV) infections have been reported in 60% to 95% of the adult population worldwide, making them one of the most common infectious conditions globally. HSV-1 and HSV-2 cause severe disease in immunocompromised patients. Therefore, the aim of this study was to provide information that could be used to reduce the incidence of genital herpes caused by HSV-1 and HSV-2. METHODS: From September 2018 to December 2020, 59,381 specimens were collected from outpatients across primary and secondary hospitals in Korea who requested U2Bio (Korea) to conduct molecular biological testing of their samples for sexually transmitted infections. In this study, the positivity rates of HSV-1 and HSV-2 were analyzed according to age, sex, and specimen type. RESULTS: In the age-specific analysis of HSV-1, the highest positivity rate (0.58%) was observed in patients under 19 years of age, whereas the lowest positivity rate (0.08%) was observed in patients aged over 70 years. In the age-specific analysis of HSV-2, the highest positivity rate (2.53%) was likewise observed in patients under 19 years of age. CONCLUSION: Our study identified differences in the infection rates of HSV-1 and HSV-2 depending on patients’ sex and age. These differences will be useful for improving disease prevention and control measures for HSV-1 and HSV-2.
format Online
Article
Text
id pubmed-8721267
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korea Disease Control and Prevention Agency
record_format MEDLINE/PubMed
spelling pubmed-87212672022-01-11 Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea Oh, Eun Ju Yuk, Young Sam Kim, Jae Kyung Osong Public Health Res Perspect Original Article OBJECTIVES: Herpes simplex virus (HSV) infections have been reported in 60% to 95% of the adult population worldwide, making them one of the most common infectious conditions globally. HSV-1 and HSV-2 cause severe disease in immunocompromised patients. Therefore, the aim of this study was to provide information that could be used to reduce the incidence of genital herpes caused by HSV-1 and HSV-2. METHODS: From September 2018 to December 2020, 59,381 specimens were collected from outpatients across primary and secondary hospitals in Korea who requested U2Bio (Korea) to conduct molecular biological testing of their samples for sexually transmitted infections. In this study, the positivity rates of HSV-1 and HSV-2 were analyzed according to age, sex, and specimen type. RESULTS: In the age-specific analysis of HSV-1, the highest positivity rate (0.58%) was observed in patients under 19 years of age, whereas the lowest positivity rate (0.08%) was observed in patients aged over 70 years. In the age-specific analysis of HSV-2, the highest positivity rate (2.53%) was likewise observed in patients under 19 years of age. CONCLUSION: Our study identified differences in the infection rates of HSV-1 and HSV-2 depending on patients’ sex and age. These differences will be useful for improving disease prevention and control measures for HSV-1 and HSV-2. Korea Disease Control and Prevention Agency 2021-12 2021-12-02 /pmc/articles/PMC8721267/ /pubmed/34965687 http://dx.doi.org/10.24171/j.phrp.2021.0146 Text en © 2021 Korea Disease Control and Prevention Agency. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Original Article
Oh, Eun Ju
Yuk, Young Sam
Kim, Jae Kyung
Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea
title Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea
title_full Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea
title_fullStr Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea
title_full_unstemmed Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea
title_short Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea
title_sort laboratory investigations of herpes simplex virus-1 and -2 clinical samples in korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721267/
https://www.ncbi.nlm.nih.gov/pubmed/34965687
http://dx.doi.org/10.24171/j.phrp.2021.0146
work_keys_str_mv AT oheunju laboratoryinvestigationsofherpessimplexvirus1and2clinicalsamplesinkorea
AT yukyoungsam laboratoryinvestigationsofherpessimplexvirus1and2clinicalsamplesinkorea
AT kimjaekyung laboratoryinvestigationsofherpessimplexvirus1and2clinicalsamplesinkorea